Table 1 Demographic and baseline clinical characteristics
From: Dexmedetomidine versus propofol sedation in flexible bronchoscopy: a randomized controlled trial
Dexmedetomidine | Propofol | P value | |
|---|---|---|---|
n | 30 | 33 | |
Age* | 58.76 ± 15.09 | 62.96 ± 9.69 | 0.19 |
Male gender | 13 (43.3) | 23 (69.7) | 0.03 |
Weight* | 76.43 ± 18.99 | 75.73 ± 15.44 | 0.87 |
ASA score* | 2 (2–2) | 2 (2–3) | 0.47 |
Baseline CO2* | 35.27 ± 9.20 | 37.40 ± 8.66 | 0.41 |
COPD | 6 | 8 | 0.86 |
IHD | 1 | 3 | 0.38 |
CHF | 0 | 2 (6.3) | 0.30 |
neuro-psychiatric medication# | 3 | 0 | 0.16 |
Procedure type | |||
BAL | 9 | 5 | 0.55 |
Bronchoscopy + TBB | 7 | 9 | |
Bronchoscopy + Cryo TBB | 6 | 5 | |
EBUS | 5 | 9 | |
Laser/balloon dilation | 3 | 5 |